{
    "Trade/Device Name(s)": [
        "HemosIL Protein C"
    ],
    "Submitter Information": "Instrumentation Laboratory Company",
    "510(k) Number": "K062430",
    "Predicate Device Reference 510(k) Number(s)": [
        "K980875"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "GGP"
    ],
    "Summary Letter Date": "September 1, 2006",
    "Summary Letter Received Date": "August 21, 2006",
    "Submission Date": "August 18, 2006",
    "Regulation Number(s)": [
        "21CFR864.7290"
    ],
    "Regulation Name(s)": [
        "Factor Deficiency Test"
    ],
    "Analyte Class(es)": [
        "coagulation"
    ],
    "Analyte(s)": [
        "Protein C"
    ],
    "Specimen Type(s)": [
        "Human citrated plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Synthetic chromogenic substrate assay"
    ],
    "Methodologies": [
        "Quantitative determination"
    ],
    "Submission Type(s)": [
        "Assay",
        "Test"
    ],
    "Document Summary": "FDA 510(k) summary for HemosIL Protein C, a quantitative synthetic chromogenic substrate assay for Protein C in human citrated plasma.",
    "Indications for Use Summary": "In vitro diagnostic test for the quantitative determination of Protein C in human citrated plasma; deficiency is associated with recurrent venous thrombosis and various acquired conditions.",
    "fda_folder": "Hematology"
}